Aug 26 (Reuters) - Advaxis Inc ADXS.O :
* Advaxis announces licensing agreement with Knight
Therapeutics and raises $25 million through direct investments from Knight
and sectoral asset management
* Says Knight is purchasing directly from Advaxis 359,454 shares at $13.91 per
share
* Says Knight will be responsible for all commercial activities related to
Advaxis current and future products
* Says Advaxis is eligible to receive double digit royalty as well as sales
milestones
* Co is eligible to receive up to $30 million in milestone payments from Knight
* Source text for Eikon ID:nMKWVw7Jsa
* Further company coverage ADXS.O